Estamos no ar no ! Saiba mais
96,81 USD
+0,21
0,22%
No fechamento Atualizado 16 de out. 16:00 EDT
Pré-mercado
Após o fechamento do mercado
96,81
0,00
0%
1 dia
0,22%
5 dias
1,16%
1 mês
4,18%
3 meses
13,28%
6 meses
28,93%
No acumulado do ano
26,91%
1 ano
30,49%
5 anos
11,38%
10 anos
57,85%
 

Sobre: Innospec Inc manufactures and sells a variety of chemicals and fuel additives. The firm organizes itself into three segments based on product type. The Performance Chemicals segment that derives maximum revenue, provides technology-based solutions for its customers' processes or products in personal care, home care, agrochemical, construction, mining and other industrial markets. The Fuel Specialties segment develops, manufactures, blends, markets and supplies a range of specialty chemical products used as additives in diesel, jet, marine, fuel oil and other fuels. The Oilfield Services segment develops and markets chemical solutions for drilling, completion, production, DRA and oil and gas applications.

Funcionários: 2.450

Notícias

Positivo
Neutro
Negativo
Sentimento 3 meses
Positivo 53,8%
Neutro 38,5%
Negativo 7,7%
Neutro
GlobeNewsWire
há 11 dias
Innospec Schedules Third Quarter 2026 Earnings Release and Conference Call
ENGLEWOOD, Colo., Oct. 05, 2026 (GLOBE NEWSWIRE) -- Innospec Inc. (NASDAQ: IOSP) today announced that it will release third quarter 2026 earnings results on Tuesday, November 3, 2026 after market close. Following the release of its results, Patrick S. Williams, President and Chief Executive Officer, and Ian Cleminson, Executive Vice President and Chief Financial Officer, will host an interactive conference call on Wednesday, November 4, 2026, at 9:00 a.m. ET.
Innospec Schedules Third Quarter 2026 Earnings Release and Conference Call
Positivo
Zacks Investment Research
mês passado
Innospec (IOSP) Up 2% Since Last Earnings Report: Can It Continue?
Innospec (IOSP) reported earnings 30 days ago. What's next for the stock?
Innospec (IOSP) Up 2% Since Last Earnings Report: Can It Continue?
Positivo
Zacks Investment Research
há 2 meses
4 Diversified Chemical Stocks to Gain Amid Stable End-market Demand
The Zacks Chemicals Diversified is expected to benefit from healthy demand across major end-use markets and the end of destocking activities. APD, DD, AVNT and IOSP are set to gain from strategic actions and demand recovery.
4 Diversified Chemical Stocks to Gain Amid Stable End-market Demand
Neutro
Seeking Alpha
há 2 meses
Innospec: Topline Is Growing As Expected
With the oilfield segment leading topline growth, even more growth should be expected as the adoption of DRA expands and the firm re-enters the Mexico market. In Q2 of 2026, revenue grew 12%, beating estimates by $34.17 million. The firm is now in a better financial position to command a higher sales multiple. The Performance chemical segment still experiences volume declines, raising concerns about the firm over investing by adding 10% capacity in a weak market.
Innospec: Topline Is Growing As Expected
Positivo
Zacks Investment Research
há 2 meses
IOSP's Q2 Earnings Surpass Estimates on Broad-Based Growth
Innospec's Q2 earnings beat estimates as all three businesses delivered revenue growth, while a debt-free balance sheet supports further investment.
IOSP's Q2 Earnings Surpass Estimates on Broad-Based Growth
Positivo
Zacks Investment Research
há 2 meses
Is Innospec (IOSP) Stock Outpacing Its Basic Materials Peers This Year?
Here is how Innospec (IOSP) and Ingevity (NGVT) have performed compared to their sector so far this year.
Is Innospec (IOSP) Stock Outpacing Its Basic Materials Peers This Year?
Neutro
Seeking Alpha
há 2 meses
Innospec Inc. (IOSP) Q2 2026 Earnings Call Transcript
Innospec Inc. (IOSP) Q2 2026 Earnings Call Transcript
Innospec Inc. (IOSP) Q2 2026 Earnings Call Transcript
Positivo
MarketBeat
há 2 meses
Innospec Q2 Earnings Call Highlights
Innospec NASDAQ: IOSP reported higher second-quarter revenue and net income as all three operating segments posted double-digit sales growth and operating-income gains, while the company continued repair and optimization work at its North Carolina Performance Chemicals facilities.
Innospec Q2 Earnings Call Highlights
Positivo
Zacks Investment Research
há 2 meses
Innospec (IOSP) Tops Q2 Earnings and Revenue Estimates
Innospec (IOSP) came out with quarterly earnings of $1.27 per share, beating the Zacks Consensus Estimate of $1.05 per share. This compares to earnings of $1.26 per share a year ago.
Innospec (IOSP) Tops Q2 Earnings and Revenue Estimates
Neutro
GlobeNewsWire
há 2 meses
Innospec Reports Second Quarter 2026 Financial Results
Strong contributions from all businesses with revenues up 12 percent and operating income up 16 percent
Innospec Reports Second Quarter 2026 Financial Results
Gráficos de preços implementados com Lightweight Charts™